Stockanalysis.com Checklist: Never Miss a Key Step
Stockanalysis.com is one of the most widely used free tools for pulling financial statements, historical data, and basic ratios on U.S.-listed stocks. The data is clean, the interface loads fast, and for a screener-free workflow it covers a lot of ground. The problem most investors run into is not the data quality. It is workflow gaps: they pull one or two numbers, miss a structural weakness in the business, and make a decision on incomplete information. This checklist closes those gaps. Work through it in order on every stock you research through stockanalysis.com.
Key Takeaways
- Stockanalysis.com provides income statements, balance sheets, cash flow statements, and basic ratios back 10+ years for most U.S. stocks.
- The platform does not calculate ROIC, VMCI Score, or intrinsic value natively, so those steps require a supplementary tool.
- Skipping the cash flow statement is the single most common mistake investors make when using stockanalysis.com.
- A 10-year view on revenue, margins, and EPS trend catches cyclical businesses that look cheap on a single-year snapshot.
- Running a parallel check in our screener fills the gaps stockanalysis.com leaves in valuation and quality scoring.
Step 1: Confirm the Business Model Before You Look at Any Numbers
Before opening the financials tab, read the company description on stockanalysis.com. Confirm you understand:
- What product or service generates the majority of revenue
- Who the customer is (consumer, enterprise, government)
- Whether revenue is recurring, transactional, or project-based
If you cannot explain the business in two sentences, the numbers will mislead you. A 28% gross margin means something very different for a software company than for a grocery retailer.
Step 2: Ten-Year Revenue and Earnings Trend
Open the Income Statement tab and switch to Annual view. Extend the window to the maximum available, typically 10 years. Check:
- Revenue is growing, not shrinking, over 5 and 10 years
- Operating income grows faster than revenue (margin expansion)
- EPS growth is consistent, not a spike from a one-time gain or share buybacks masking flat net income
- No year shows a revenue decline of more than 15% without an obvious external cause (pandemic, commodity cycle)
Apple (AAPL) serves as a clean benchmark here. Revenue grew from roughly $274 billion in fiscal 2020 to $391 billion in fiscal 2024, with operating margins expanding from 24% to 31% over the same period. EPS grew at a compound rate of about 19% annually, with buybacks contributing roughly 4 to 5 points per year. That is the type of consistent trend you want to see.
Step 3: Gross Margin, Operating Margin, Net Margin History
Still on the Income Statement, calculate or pull the margin columns:
- Gross margin is stable or expanding over 5 years
- Operating margin does not swing more than 5 percentage points year to year in a non-cyclical business
- Net margin trend matches operating margin trend (a divergence signals one-time items or tax noise)
A company with a 35% gross margin falling to 28% over five years deserves a hard look at competitive pricing pressure before you go any further.
| Margin Type | Healthy Range (Non-Cyclical) | Red Flag |
|---|---|---|
| Gross Margin | Stable or expanding | Declining 3+ years in a row |
| Operating Margin | Stable or expanding | High variance year-to-year |
| Net Margin | Tracks operating margin | Diverges significantly from operating |
| Free Cash Flow Margin | 10%+ for quality names | Persistently below operating margin |
Step 4: Balance Sheet Snapshot
Switch to the Balance Sheet tab. You are checking financial health and the ability to survive a bad year without diluting shareholders.
- Total debt-to-equity is below 1.5 for most non-financial businesses
- Current ratio (current assets divided by current liabilities) is above 1.0
- Goodwill and intangibles are not more than 40% of total assets; if they are, note the acquisition history
- Cash and short-term investments cover at least 1 year of operating expenses
Microsoft (MSFT) illustrates the fortress balance sheet. As of early 2026, it holds over $70 billion in cash and short-term investments against long-term debt of roughly $50 billion, giving it a net cash position that makes its P/E of 32.1 less alarming than the headline number suggests.
Step 5: Cash Flow Statement Is Non-Negotiable
The cash flow statement is where reported earnings either confirm or fall apart. Open the Cash Flow tab.
- Operating cash flow is positive in every year (or every year except a startup phase)
- Free cash flow (operating cash flow minus capital expenditures) is positive and growing
- Capital expenditures as a percentage of revenue are stable; a sudden spike signals a heavy investment cycle that compresses near-term FCF
- Share-based compensation is disclosed; if it exceeds 5% of revenue annually, it is diluting shareholders even when net income looks positive
A company reporting $2 billion in net income but generating only $400 million in free cash flow is telling you something important. The gap usually lives in working capital changes or aggressive capitalization of expenses.
Step 6: Key Ratios Tab
Stockanalysis.com surfaces a ratios page for each stock. Run through it with the following filters:
- P/E ratio: compare against the stock's own 5-year median, not just the sector average
- P/B ratio: below 3.0 is a rough guide for value; BRK.B at a P/B of 1.5 is the benchmark for a well-run conglomerate
- EV/EBITDA: below 15 for mature businesses; compare against peers in the same industry
- Dividend yield (if applicable): verify payout is covered by free cash flow, not just earnings
Note what stockanalysis.com does not calculate directly: ROIC, VMCI Score, and intrinsic value. Apple's ROIC of 45.1% is one of the highest in the S&P 500. You will not find that number on stockanalysis.com. For ROIC and a composite quality score, run the stock through our screener which tracks 120 indicators including all five VMCI pillars: Value (35%), Quality (30%), Integrity (15%), Growth (12%), and Risk (8%).
Step 7: Segment and Geographic Revenue Breakdown
Many companies hide concentration risk in a summary income statement. Look for the segment data, often available in the annual financials or linked from the stockanalysis.com page to the SEC filing.
- No single customer accounts for more than 20% of revenue
- Geographic exposure is diversified (or you have a thesis for why concentration is acceptable)
- Revenue from declining segments is shrinking, not masking growth in core operations
Step 8: Management and Insider Ownership
Stockanalysis.com links to SEC filings. Pull the most recent proxy (DEF 14A) and check:
- CEO and CFO own meaningful shares (above 1% for large caps, above 5% for smaller companies)
- Insider selling is not consistent and heavy over the past 12 months
- Executive compensation is tied to returns on capital or free cash flow growth, not just revenue
Step 9: Compare Against a Second Source
Stockanalysis.com is strong on historical financials and basic ratios. It is thinner on valuation models and composite scoring. After completing the above steps, run the stock through our DCF calculator to generate an intrinsic value range. Input the 10-year FCF trend you pulled from stockanalysis.com into the model and stress-test it with three growth scenarios: base, conservative, and optimistic.
This two-tool workflow, stockanalysis.com for historical data plus ValueMarkers for valuation and scoring, takes about 20 minutes and covers every critical dimension.
Further reading: SEC Investor.gov · FINRA
Why stock research checklist Matters
This section anchors the discussion on stock research checklist. The detailed treatment, formula, and worked examples appear in the body of this article above. The points below summarize the most important takeaways for value investors who want to apply stock research checklist in real portfolio decisions. ValueMarkers exposes the underlying data on every covered ticker via the screener and stock profile pages, so the concepts in this article translate directly into actionable filters.
Key inputs for stock research checklist
See the main discussion of stock research checklist in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using stock research checklist alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.
Sector benchmarks for stock research checklist
See the main discussion of stock research checklist in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using stock research checklist alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.
Related ValueMarkers Resources
- Enterprise Value to EBITDA (EV/EBITDA) — Enterprise Value to EBITDA is the metric used to how cheaply a stock trades relative to its fundamentals
- Pb Ratio — Glossary entry for Pb Ratio
- Pe Ratio — Glossary entry for Pe Ratio
- Stock Analysiscom — related ValueMarkers analysis
- Stockanalysis — related ValueMarkers analysis
- Operating Margin Vs Net Margin Which One — related ValueMarkers analysis
Frequently Asked Questions
What is stockanalysis.com?
Stockanalysis.com is a free financial data platform providing income statements, balance sheets, cash flow statements, and key ratios for U.S.-listed stocks and ETFs. It sources data from SEC filings and financial data providers, making it one of the more accurate free resources for historical fundamental data.
How do you calculate stockanalysis.com?
Stockanalysis.com does not require calculation; it retrieves and displays financial data from public filings. Investors use it by navigating to a ticker, selecting the relevant financial statement (income, balance sheet, or cash flow), and choosing the desired time period (annual or quarterly). The ratios section auto-calculates from reported figures.
Why is stockanalysis.com important for investors?
Stockanalysis.com centralizes financial data that would otherwise require downloading SEC filings manually. For value investors, 10 years of consistent free cash flow data is more informative than a single-year earnings report. Access to this historical view at no cost lowers the barrier to fundamental analysis significantly.
How to use stockanalysis.com in stock analysis?
Start with the income statement to check revenue and margin trends over 10 years, then move to the balance sheet for debt and liquidity, then to the cash flow statement to confirm earnings quality. Use the ratios tab for P/E, P/B, and EV/EBITDA comparisons. Supplement with a valuation tool like the ValueMarkers DCF calculator for intrinsic value estimates.
What is a good stockanalysis.com for value stocks?
A stock that looks strong on stockanalysis.com for value investing shows consistent free cash flow growth, stable or expanding margins, low debt relative to earnings, and a P/E or EV/EBITDA below its 5-year median. Berkshire Hathaway (BRK.B), Johnson & Johnson (JNJ), and Coca-Cola (KO) are examples of names that clear most of these filters across multiple years.
What are the limitations of stockanalysis.com?
Stockanalysis.com does not calculate ROIC, does not provide intrinsic value estimates, does not include a composite quality score, and has limited screening functionality compared to dedicated screeners. Its data coverage for international stocks is also narrower than for U.S.-listed names. For those gaps, a supplementary platform like ValueMarkers covers the missing dimensions.
Run through this checklist before your next investment decision. When you reach Step 9, our screener has the 120 indicators and VMCI composite score ready to fill the gaps stockanalysis.com leaves behind. Compare stockanalysis.com against other platforms at our comparison tool.
Written by Javier Sanz, Founder of ValueMarkers. Last updated April 2026.
Ready to find your next value investment?
ValueMarkers tracks 120+ fundamental indicators across 100,000+ stocks on 73 global exchanges. Run the methodology above in seconds with our stock screener, or see today's top-ranked names on the leaderboard.
Related tools: DCF Calculator · Methodology · Compare ValueMarkers
Disclaimer: This content is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.